Future Medicine India – Drug Packs Drug Packs Archives | Future Medicine India

Drug Packs

Finally, a drug for Alzheimer’s?

The US Food and Drug Administration (FDA) approved aducanumab, the first new drug for Alzheimer’s disease in 18 years.

Read More..

Benefits of ifosfamide continue to outweigh risks: EMA

The Pharmacovigilance Risk Assessment Committee (PRAC) of EMA has concluded that the benefits of ifosfamide solutions for infusion continue to outweigh their risks in the treatment of different types of cancers, including various solid tumours and blood cancers such as lymphomas.


In a study funded by the National Institutes of Health (NIH), researchers tested a novel combination treatment approach on mice with tumours with characteristics similar to human astrocytomas — a type of slow-growing glioma—and found tumour regression in 60 percent of the mice treated.


A treasure trove of therapeutics?

Cyanobacteria are promising but still unexplored natural resources offering a wealth of chemicals for the discovery of pharmaceutical compounds and new drugs.

N S Arun Kumar

Remove all ranitidine products from market: US FDA

The US FDA has requested manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately.


Novel vaccine effective in people without prior dengue

A novel tetravalent dengue vaccine candidate developed by Takeda is found demonstrating similar degrees of protection in individuals who had and had not been previously infected with dengue.


Entacapone use not linked to higher risk of prostate cancer: USFDA

Entacapone, the commonly used medication for Parkinson’s disease is not associated with increased risk of prostate cancer, said USFDA, confirming the safety of the drug in a recent announcement. In March 2010, the FDA warned the public about a possible risk of prostate cancer with the entacapone component of the product Stalevo, based on the […]